Decision-making on listing new medicines for public funding in New Zealand: the case of 'new' type 2 diabetes medications
IntroductionNew medicines for the management of type 2 diabetes became available internationally in 2005, yet only in 2018 did the first of these become available in New Zealand. Access to these new medicines in New Zealand is largely dependent on decisions made by the Pharmaceutical Management Agen...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
CSIRO Publishing
2022-01-01
|
| Series: | Journal of Primary Health Care |
| Subjects: | |
| Online Access: | https://www.publish.csiro.au/hc/pdf/HC21122 |